Your source for the latest medtech news from AdvaMed® and our members.
AdvaMed® announced that Lester B. Knight, a founding partner of RoundTable Healthcare Partners and former Chief Executive of Allegiance, will receive the 2022 AdvaMed® Lifetime Achievement Award.
AdvaMed® announced that Lester B. Knight, a founding partner of RoundTable Healthcare Partners and former Chief Executive of Allegiance, will receive the 2022 AdvaMed® Lifetime Achievement Award.
AdvaMed® will hold a conference call for news media on the upcoming Medtech Conference and legislative/policy issues in front of the industry today.
AdvaMed® urged California’s First District Court of Appeal to overturn an erroneous decision by the trial court that has the potential to impose unfair and unwarranted liability upon companies that…
If you have media inquiries, please contact:
Jim Jeffries, Senior Vice President, Public Affairs, 202-434-7242
The Advanced Medical Technology Association® (AdvaMed®), the world’s largest trade association representing medical device manufacturers, has worked alongside FDA and Congressional leaders to negotiate a final agreement that provides FDA…
This week, the Senate and House unanimously approved the reauthorization of the Small Business Innovation Research and Small Business Technology Transfer (SBIR/STTR) programs for three years. Since early 2021, AdvaMed®…
The Advanced Medical Technology Association® (AdvaMed®), which hosts the annual Medtech Conference, announced the first selection of headline speakers for the upcoming event in Boston from October 24-26, 2022.
WASHINGTON, D.C. – Today, the Advanced Medical Technology Association® (AdvaMed®), the world’s largest trade association representing medical device manufacturers, released the following statement from President and CEO Scott Whitaker in response…
Brought to you by AdvaMed®, Medtech POV with Scott Whitaker is a podcast that covers the intersection of medtech and policy from every perspective.
Scott Whitaker, President and CEO of AdvaMed®, made a statement on EPA’s naming of 23 commercial sterilization facilities as the subject of community meetings over possible health risks.